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INTRODUCTION
Cardiopulmonary bypass (CPB) and cardiac arrest allow the 
surgeon to perform controlled anastomoses during coronary 
artery bypass graft surgery (CABG). However, this comes at a 
cost. A systemic inflammatory response is a risk for organ 
damage and thus mortality and morbidity. Beating heart surgery, 
or off-pump CABG (OPCAB), was re-introduced to attenuate 
this effect. Many studies demonstrated very optimistic results in 
favour of OPCAB compared to CABG with conventional CPB. 
However, not everybody is convinced by the benefits, and this 
was addressed in a review on whether it would be beneficial to 
change to OPCAB.(1) In this study, the combined prevalence of 
mortality, myocardial infarction, stroke and new dialysis was 4%. 
To improve this with even 25% would require 10 600 patients, 
which is impossible in the average private cardiac practice in 
South Africa. Many randomised controlled studies could not 
demonstrate clear benefits and surgeons are losing interest in 
the OPCAB technique.(2) This is confirmed by a review from the 
Cochrane Libraries. Based on the current evidence, CABG 
should be done with conventional CPB.(3)
A new CPB system has been developed. The argument is that 
 minimal extracorporeal circulation (MECC or minibypass) 
should reduce the inflammatory response associated with 
conventional CPB.(4) This system allows cardiac arrest, while 
maintaining the circulation. The lack of a venous reservoir with 
reduced priming volume, less cell trauma by the centrifugal 
pump driven by a magnet, and less blood-synthetic contact, 
all attribute to this possible beneficial effect. A reduction in 
markers of inflammation should result in reduced organ damage 
and therefore reduced postoperative complications. 
Introduction: The systemic infl ammatory response asso-
ciated with cardio-pulmonary bypass (CPB) is detri-
mental to organ function in varying degrees. Minimal 
extracorporeal circulation (MECC) assumes an atten-
uation of these deleterious effects. The aim of this study 
was to compare conventional CPB (CCPB) with MECC, 
in a population of patients who had their CABG done in 
a private practice in South Africa. 
Methods: Two historical cohort analytical studies were 
done on patients who had isolated CABG done by one 
surgeon in the Mediclinic Bloemfontein. Patients who 
had their CABG done using CCPB were compared sta-
tistically using logistic regression to those who had their 
CABG done with MECC. A propensity score matching 
was also used to compare the 2 groups. In a second 
follow-up study, a once-off lactate on arrival in the inten-
sive care unit was compared. A qualitative assessment 
of the technique by the various role-players in theatre 
was added to the initial study.
Results: The primary CCPB group had 1 572 patients. 
The MECC group comprised 367 patients.  No statisti-
cally signifi cant outcome difference was found in terms 
of mortality, major morbidity, post-operative blood loss 
or usage of homologous blood. Once the 2 groups were 
evenly matched, patients with MECC had a better serum 
creatinine postoperatively, but renal dialysis could not 
be avoided. Patients with MECC also had a statistically 
shorter hospital stay. The second study (CCPB n=63 and 
MECC n=100) confi rmed the shorter hospital stay. 
There was no difference in the lactate value between the 
2 groups. In general, there are varying levels of enthu-
siasm among the theatre specialists for a MECC 
strategy.
Conclusions: MECC protects the kidneys, but not so 
much against renal dialysis. MECC patients could stay 
for a somewhat shorter time in hospital. Tissue per-
fusion based on a once-off lactate level was equal. MECC 
might be technically more demanding. This article is an 
important addition to the literature that adds a local 
perspective.  SAHeart 2019;16:22-27
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“Evidence based medicine is the conscientious, explicit and 
judicious use of current best evidence in making decisions 
about care of individual patients”.(5) The theoretical information 
regarding the beneficial effects of MECC, was thus introduced 
and applied in a private cardiac surgery practice. 
The aim of this article was to report on 2 separate, but con-
secutive studies that were done to compare the effect of 2 
CPB strategies in a population of patients who had their CABG 
done in a private practice. One study looked at the clinical 
outcome and a second study specifically compared a single 
blood-lactate level. These patients had their CABG done with 
either conventional cardiopulmonary bypass (CCPB) or mini-
mal extracorporeal circulation (MECC). It is the clinical out-
come that interests the surgeon, anaesthetist, referring 
cardiologist and obviously the patient. From a perfusion point 
of view, blood lactate is one way of verifying the adequacy of 
perfusion.(6) Blood lactate of 4.0mmol/l or higher during CPB, is 
an indication of tissue hypoperfusion, and is associated with 
more postoperative complications.(7)
METHODS
Two historical cohort analytical studies were done. For the first 
study, all patients who had their isolated CABG done with 
cardiopulmonary bypass by 1 surgeon (MJS), in 1 hospital from 
2000 - 2015, were included. Patients who required additional 
procedures were the only patients that were excluded. Con-
ventional bypass (CCPB) was used from November 2000 
until November 2011. In December 2011, all CCPB cases for 
CABG were switched to MECC. Again, all the patients oper-
ated on consecutively for isolated coronary artery disease until 
December 2015, were included. After December 2015, MECC 
was the CPB technique until July 2016.
The conventional bypass system used the Inspire® oxygenator 
and a roller pump ( S5 Stöckert®). The priming solution was 
2 500ml. The minisystem consisted of the Synergy® membrane 
oxygenator, a centrifugal cone driven by the heart lung ma-
chine (S5 Stöckert®), and a closed loop with surface treatment 
(PH.I S.I.O.®). The priming solution was 500ml. Activated 
clotting time was maintained above 400 seconds in both 
techniques. The standard myocardial protection was inter-
mittent, antegrade, cold 1:1 blood:cardioplegia. Systemic tem-
perature drifted down to 33 - 34°C, and patients were then 
actively rewarmed. Cell saving was used in every case. 
These 2 groups of CCPB and MECC patients were compared 
regarding clinical outcomes using univariate analysis, stepwise 
logistic regression, and a propensity score matched analysis. 
Lastly, the experience of the various role-players in theatre was 
added as part of this clinical appraisal. This was done with a 
simple, subjective questionnaire about the overall experience 
with minibypass.
In the second study, CCBP was compared with MECC regarding 
a once-off lactate level on arrival in the intensive care unit 
(ICU). These procedures were done in the same institution by 
the same surgeon. The last 100 patients who had their CABG 
done with MECC (April 2015 until July 2016) and all the 
subsequent patients who had their CABG done again with 
CCBP (July 2016 until July 2017) were compared. The data of 
a number of patients in the MECC group were thus used in 
both studies. 
Both studies were approved by the Health Sciences Research 
Ethics Committee of the University of the Free State (UFS). 
Individual patient consent was not obtained, as the names were 
not included in the database used by the researchers.
Basic demographic information was obtained from an existing, 
personal and ongoing data source. The clinical outcomes 
assessed were mortality at any time while in hospital and major 
morbidity (defined as re-exploration, stroke, prolonged ventila-
tion, new renal dialysis, and sternal dehiscence). Other clinical 
outcomes included mediastinal drainage measured over 48 
hours, homologous red blood cell replacement, a creatinine rise 
of 50% from a preoperative baseline, dialysis, and length of 
hospital stay (LOS). A fast-track approach was not applied 
with the change to MECC.
Blood lactate level was the primary outcome in the second 
study. A Siemens Rapidpoint 500 multi analyzer is permanently 
stationed in the ICU and this was used to do routine blood gas 
analysis, which included a lactate level. Although other surro-
gates for perfusion adequacy are routinely used, these were not 
documented for comparison. The 2 groups, CCPB and MECC, 
were once again compared regarding their EuroSCORE II, 
body surface area (BSA) and CPBtime (CPBt). CPBt and aortic 
cross clamp time were not available in the first study. Sec-
ondary outcomes compared, were mortality, morbidity and 
LOS. Serum creatinine was not evaluated again.
The Department of Biostatistics at the Faculty of Health 
Sciences of the University of the Free State did the statistical 
analysis. The results were summarised by frequencies and 
percentages (categorical variables), medians and means, and 
standard deviations or percentiles (numerical variables). Uni-
variate analysis consisted of Mann-Whitney tests for numerical 
variables and chi squared or Fisher’s exact tests for categorical 
variables. Stepwise logistic regression was performed to iden-
tify independent predictors of outcome. A propensity score 
matched analysis selected 367 CCPB patients to correspond 
with the MECC patients regarding age, diabetes mellitus, hyper-
tension, body mass index, intra-aortic balloon pump, and 
Parsonette score. 
24
MINIMAL EXTRACORPOREAL CIRCULATION
RESULTS
Between November 2000 and November 2011, 1 572 patients 
had their isolated CABG done with CCPB. From December 
2011 until December 2015, another 367 patients had MECC 
as a bypass technique. The statistical comparison is depicted 
in Table I. No significant differences were found in terms of 
mortality, morbidity and LOS. The CCPB patients had 46ml 
more mediastinal drainage over 48 hours compared to the 
MECC group. In both groups, 20% of patients required red 
blood cells from the blood bank. Acute kidney injury or a 
50% rise in serum creatinine complicated 7.1% and 4.9%, 
respectively, in the CCPB and MECC groups (p=0.13). Some 
patients needed formal renal dialysis, 1.2% and 1.7% respec-
tively (p=0.45).
It was clear that the basic demographic information of these 2 
groups differed significantly (Table II). Therefore in the pro-
pensity score matched analysis, 367 patients from the CCPB 
group were evenly matched with the 367 patients who had 
their CABG done with MECC. The mean propensity scores in 
both groups were 0.29. Two signif icant differences in the 
outcome were identified between these matched groups 
(Table III). A rise in creatinine was now more prominent in the 
CCPB groups, with 10.4% of the patients having a significant 
increase in postoperative serum creatinine compared to only 
4.9% from the MECC group. The Odd Ratio (OR) for patients 
to develop a higher serum creatinine was 0.42 with the MECC 
(95% Confidence Interval [CI] 0.21;0.78). This was confirmed 
with the stepwise logistic regression, where MECC was shown 
to have a protective effect on the kidneys, but not to the 
point of limiting the number of patients who required dialysis. 
Parsonette score and pre-operative Chronic Kidney Disease III 
(CKDIII) predicted renal failure requiring dialysis. In the step-
wise logistic regression, MECC did not contribute to any other 
commonly reported outcome – except for the more favourable 
serum creatinine post-operatively. 
The second difference from a statistical point of view was the 
dissimilarity in LOS (Table III). CCPB patients stayed a mean of 
6.4 days (median 5 days) and MECC patients 5.9 days (also a 
median 5 days). Although the medians are the same, there is 
some difference in the distributions. However, this difference in 
LOS was only when one compares percentage of patients who 
stayed longer than 6 days (CCPB 45.0% and  MECC 36.3%). 
There was no difference in the 2 groups when the percentage 
of patients who stayed longer than 7 days (CCPB 21.3% and 
MECC 20.8%) was compared. The difference in LOS is pro-
bably, at most, half a day in favour of the MECC technique. 
Two surgeons, 7 anaesthetists and 2 perfusionists answered a 
simple questionnaire to give information about their experi-
ence with MECC. All 11 specialists were aware of this bypass 
technique. One surgeon had a positive impression and 2 
TABLE I: Outcomes of CCPB and MECC groups.
CCPB
n=1572
MECC
n=367 P 
Mortality 2.22% 2.45% p=0.79
Morbidity 5.8% 5.7% p=0.96
Mediastinal drainage (mean) 646ml 600ml p=0.06
RBC 20% 19.3% p=0.79
S-Creatinine 7.1% 4.9% p=0.13
Dialysis 1.2% 1.7% p=0.45
LOS (mean) 5.9 days 5.9 days p=0.17
LOS = length of hospital stay, RBC = red blood cells, S = serum.
TABLE III: Outcomes of propensity score matched groups.
CCPB
n=367
MECC
n=367 P 
Mortality 3.54% 2.45% p=0.39
Morbidity 7.1% 5.7% p=0.43
Mediastinal drainage (mean) 611ml 600ml p=0.69
Mediastinal drainage 
(median)
550ml 500ml p=0.06
RBC 22.3% 19.3% p=0.32
S-Creatinine 10.4% 4.9% p<0.01
Dialysis 2.2% 1.7% p=0.75
LOS (mean) 6.4 days 5.9 days p=0.17
LOS (median) 5 days 5 days p=0.02
LOS = length of hospital stay, RBC = red blood cells, S-Creatinine = a creatinine rise 
of 50% from a pre-operative baseline.
TABLE II: Pre-operative demographic information of 
CCPB and MECC groups.
CCPB
n=1572
MECC
n=367 P 
Age (median) 61 63 p<0.01
Diabetes mellitus 26% 34% p<0.01
Hypertension 63% 69% p=0.02
BMI 30.6 31.6 p<0.01
IABP 18% 26% p<0.01
Parsonette (mean) 7.5 9.2 p<0.01
BMI = body mass index kg/m2, IABP =  intra-aortic balloon pump.
25
20
19
Vo
lu
m
e 
16
 N
um
be
r 1
anaesthetists had a definite negative attitude toward mini-
bypass. The other 8 specialists could not really determine a 
difference. One surgeon found MECC to be user-friendly, 
whereas 4 anaesthetists could not distinguish a difference. The 
rest (6 specialists) thought MECC was more challenging. At 
the time of the investigations, only 2 specialists would prefer to 
continue with MECC – 1 surgeon and 1 anaesthetist. Four 
anaesthetists felt unhappy about continuing with MECC. The 
rest (5 specialists) believed certain subgroups could benefit 
from MECC.
For the second study, 63 consecutive patients who had an 
isolated CABG done with CCPB (July 2016 until July 2017) 
were compared with the last 100 consecutive patients who 
had MECC (April 2015 until July 2016) as a bypass technique. 
The median lactate level on arrival in the ICU was 3.5mmol/l 
(mean 4.11mmol/l) in the CCPB group and 3.6mmol/l (mean 
4.03mmol/l) in the MECC group (p=0.84). As expected, lac-
tate itself correlated, but only weakly (Spearman correlation 
coefficients), with BSA and CPB time, but not with the 
EuroSCORE II (Table IV). Lactate was not associated with 
death or major morbidity and did not correlate with LOS.
Although lactate level on arrival in the ICU was the primary 
outcome, other comparisons were again made. The 2 groups 
did not differ in terms of their EuroSCORE II, BSA and CPBt, 
with p values of 0.31, 0.81 and 0.84 respectively (Table V). As 
far as outcomes were concerned, no difference was seen in 
mortality or morbidity between the groups CCPB and MECC 
(Table VI). However, this second study confirmed the better 
LOS in patients who had their CABG done with MECC. The 
median LOS was 6 (7.6 mean) days and 5 (6.5 mean) days 
respectively (p=0.01 Mann-Whitney, 95%CI -1;0.0). 
DISCUSSION
Since the start of this practice, by the end of 2000 CCPB was 
the CPB technique until December 2011. The CCPB technique 
was changed to MECC during December 2011 based on the 
advantages in the literature associated with MECC. A policy 
change was again introduced from July 2016 back to CCPB. 
Apart from the combined numbers in review articles, this study 
is one of the larger, single institutional studies to compare 
CCPB with MECC.(8) The fact that a reduction in the inflam-
matory response would result in less adverse effects associated 
with CPB, made sense.(9) Unfortunately, the literature is not 
that convincing, and the clinical results are rather equivocal. 
This study’s results are no different. Not only did the study by 
Svitek, et al. demonstrate no difference in the anti-inflam-
matory response, they also found no difference in the clinical 
outcome.(10) Admittedly, it was a small study that involved 
only 54 patients. Another study showed improvement in 
inflammatory markers following MECC.(11) Larger studies seem 
to illustrate a difference in favour of MECC.(12)
At first glance, the impression is that this study would have a 
similar outcome to the 2 smaller studies mentioned. There 
was no difference in the common postoperative outcomes 
(Table I). However, this study confirmed the perception that 
patients have become, over time, a higher postoperative risk for 
mortality. Although the Parsonette score is no longer used to 
assess operative risk, it was still useful to demonstrate the 
change in patient demographics (Table II). Since the EuroSCORE 
changed in 2012 to an updated version (EuroSCORE II), 
Parsonette was applied in this first part of the study. It was 
considered to be inaccurate to use 2 different EuroSCOREs. 
Once the 2 populations were comparable, 2 differences 
TABLE V: Pre- and intra-operative comparisons in the 
lactate study.
CCPB
n=367
MECC
n=367 P 
Mean Median Mean Median
EuroSCORE 2.73 1.41 3.93 1.89 0.31
BSA (m2) 2.06 2.06 2.04 2.03 0.81
CPBt (minutes) 81.84 80 78.78 81 0.84
BSA = body surface area, CBPt = cardiopulmonary bypass time.
TABLE VI: Outcome comparisons in the lactate study.
CCPB
n=63
MECC
n=100 P 
Mortality (%) 1 (1.59) 1 (1) p=1.00
Morbidity (%) 2 (3.17) 8 (8) p=0.32
LOS (median days) 6 5 p=0.01
LOS (mean days 7.6 6.5 P=0.01
LOS = length of hospital stay.
TABLE IV: Correlation with lactate levels (n=163).
Correlation P 
EuroSCORE II -0.05 P=0.55
BSA 0.22 p=0.01
CPBt 0.33 p<0.01
LOS -0.01 p=0.85
BSA = body surface area m2, CPBt = time, LOS = length of hospital stay,
S-Creatinine = a creatinine rise of 50% from a pre-operative baseline.
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became clear. Renal function and LOS seemed to be better 
with MECC (Table III). It was the serum creatinine that 
improved. MECC did not protect the kidneys enough to avoid 
dialysis. This observation is in line with Benedetto, et al.(13) Their 
study was also a propensity score matched analysis. They used 
a different criterion to diagnose kidney injury, but still the 
incidence of kidney injury was reported as 42% vs. 29% (for 
CCPB and MECC respectively). Again, there was no difference 
in the prevalence of patients requiring renal dialysis. In their 
series, the OR for renal injury with MECC was 0.61 (95%CI 
0.38;0.97), whereas the OR for renal impairment postopera-
tively in the local series was 0.42 (95% CI 0.21;0.78).
Although the LOS was initially similar, the MECC group stayed 
shorter (mean 5.9 days as opposed to 6.4 days), when the 2 
population groups were evenly matched (Table III). It probably 
means that the higher risk (latter period) group (MECC) stayed 
the same number of days as the lesser risk (former period) 
group (CCPB) – but after the propensity score matching, the 
MECC patients stayed somewhat shorter. This half a day longer 
in hospital can probably be explained by the fact that more 
patients with CCPB had raised postoperative serum creatinine 
levels. A shorter LOS was also reported by Immer, et al.(14) The 
LOS dropped from 9.3 days - 8.1 days with MECC. They did 
not however investigate postoperative renal function, except 
for the diuresis in the first 6 hours in the ICU, which was similar 
in the 2 bypass groups. In a large prospective study, no dif-
ference was seen in the LOS between CCPB and MECC 
patients.(15) A slim improvement in LOS with MECC was 
reported by Wang.(16) In their meta-analysis, the LOS in the 
3 randomised trials was not statistically different, nor in 
the 2 cohort studies. However, the combination demonstrated 
a better LOS in favour of MECC, although it was only 18 hours. 
Many studies report less mediastinal drainage and fewer units of 
red blood cells from a blood bank.(8) This study could not 
however confirm this (Tables I and III). Post-operative drainage 
and red blood cell transfusion were also similar in the 2 groups 
in the study by Remedi. However, they reported a higher 
transfusion rate intra-operatively.(12) Low homologous red 
blood cell consumption in this practice has been reported 
previously.(17) 
Lactate is the conjugate base after lactic acid has lost a proton. 
This is the result of glucose and pyruvate metabolism in a 
hypoxic environment, but also when there is hypoperfusion of 
the liver as during CPB.(18) In contrast to this study, Puehler and 
colleagues established a difference in the lactate on arrival in 
the ICU between CCPB and MECC patients.(15) As a matter of 
interest, they found no difference between the lactate on arrival 
between MECC and OPCAB patients. They commented that 
the organ and tissue perfusion with MECC and OPCAB were 
better than with CCPB. They excluded patients in their series 
with a body mass index (BMI) of ≥30kg/m2. In the local study, 
the mean BMI was >30kg/m2 (Table II). This study demonstrated, 
as expected, a correlation between lactate and body surface 
area (BSA) and with CPBt (Table IV). 
The fact that most of the in-theatre specialists were less 
enthusiastic about minibypass can be attributed to the technical 
challenges. The heart acts as the reservoir for blood volume 
and if too much blood is drained, the bypass circulation stops. 
A fuller heart makes distal anastomosis more challenging. The 
2 specialists who were keen to continue with MECC were a 
surgeon who had the impression that renal function recovered 
more quickly with MECC, and an anaesthetist who wanted to 
get more experience with MECC. The other specialists had 
reservations about MECC as a bypass technique, although 
MECC might have a place for selected patients. 
Any amount of air in the venous system will also bring the 
circulation to a standstill.(19) The conventional system is much 
more forgiving.(20) The danger of air during true open-heart 
surgery is more real, and, therefore, as a local decision policy, 
no heart valve surgery with MECC was done. However, 
Baumbach, et al. and Wang, et al. reported a superior outcome 
of MECC in a population of valve surgery.(21,16) It should also be 
borne in mind that with MECC there is no back-up of a 
cardiotomy sucker to collect spilled blood in the chest back to 
the circulation. All blood gets sucked away to the cell saver, 
where plasma (clotting factors) and platelets are washed out. 
This could lead to coagulation pathology and more bleeding. 
Some studies report no MECC in redo cases.(9,13) Among the 1 
939 patients in the first study of the local series, 10.7% had a 
second or further sternotomy. No adverse effects related to 
bleeding or air were documented in the local series. 
LIMITATIONS
Acute renal impairment after cardiac surgery is complex. 
Parolari, et al. found 15 predictors of post-operative acute kid-
ney injury.(22) Recently, it was also reported that determining 
the pre-operative renal function reserve (RFR), even among 
patients with a normal glomerular filtration rate, could predict 
post-operative renal impairment.(23) Not all of these predictors 
were available in the local series.
Each patient’s data are available in an existing and ongoing, self 
maintained Excel database. One person, the surgeon, collects 
this information and it is not audited by an independent person. 
Standard definitions are used, but they are still subjected to the 
surgeon’s interpretation. Other variables are the number of 
anaesthetists and different perfusionists involved – each with his 
or her subtle differences in technique. The fact that the study 
was done over a long time span could also have had an influence 
on the outcomes. Larger numbers will always be preferred for 
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better statistical power. A randomised trial would however 
probably be a better way to compare. Yet, patients were not 
individually selected for a bypass technique – but followed the 
standing policy, which changed twice over 17 years. Hopefully 
the issue of non-randomisation was further addressed with 
the propensity score matching. A cost analysis was not done, 
but the MECC pack is about 6.5% more expensive than the 
CCPB pack.
CONCLUSIONS
From the first study, it was clear that patients are currently at a 
higher operative mortality risk than a decade or 2 ago. There 
was not much difference in the outcome between the 2 
techniques, even if one compares exactly similar groups – as 
was done with the propensity score matched analysis. One can 
conclude that MECC protects the kidneys, but not to the 
point where dialysis is avoided. The positive consequence of 
this improved renal function, is that, statistically, patients with 
MECC stayed for a slightly shorter time in hospital. It further-
more seems that at the time of the first study, the different 
role-players in theatre were less enthusiastic about the MECC 
procedure. From the second study, it would appear that at 
least the tissue perfusion, as measured by the once off blood 
lactate, is not worse with MECC. MECC is a safe alternative in 
patients who could benefit from a bypass technique that is 
kinder to the kidneys. 
This report does not necessarily contribute new information. 
The data from this study may be utilised to improve the power 
of future meta-analyses on this subject. Such a reflection is also 
important after application of information from elsewhere in a 
local context. 
Conflict of interest: none declared.
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